John Gould

John Gould's practice spans a broad range of healthcare compliance counseling, transactional, and public policy matters for pharmaceutical, biological, and medical device manufacturers, and focuses on drug price reporting, the federal anti-kickback statute, and market access issues. In the drug pricing area, Mr. Gould advises on Medicaid, Medicare, Department of Veterans Affairs, and 340B Program requirements, as well as state drug pricing laws. Mr. Gould assists clients with price reporting restatements, investigations, litigation, and public comments on proposed rules. Mr. Gould leads interdisciplinary teams to assist clients with managed markets issues, including customer contracts, limited distribution networks, and patient support programs.

J.D., University of Pennsylvania Carey Law School, 2003, magna cum laude, Order of the Coif; Master of Bioethics, University of Pennsylvania, 2003; B.S., Molecular Biophysics and Biochemistry, Yale University, 1999, magna cum laude